InsidersTradesSigma
Bavarian Nordic A/S Stock: price and insider trades · Denmark · Finanstilsynet DK
Track the Bavarian Nordic A/S stock price and the full insider trade history of the company, a listed equity based in Denmark. Shares are listed on DK DK, under the oversight of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Bavarian Nordic A/S has logged 81 reports. Market capitalisation: €14bn. The latest transaction was disclosed on 13 May 2026 (Other). Among the most active insiders: Unknown. Every trade is accessible without an account.
81
Insider Decl.
0
Thresholds
€717,105
7 ops.
Buy Volume
€3m
4 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 889 of 25,451 companies
81.2
score / 100
Value84
Quality78
FCF yld9.4%
Earn yld9.5%
EV/EBITDA5.8x
ROE9.7%
Gross mgn49%
Net mgn22%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 May 2026
Declarations81 total
771 shares@ DKK 188.300.0001% mcap0.2% of flowShareOutside a trading venueDK:1442171
10,642 shares@ DKK 177.650.0018% mcap2.1% of flowShareOutside a trading venueDK:1426172
983 shares@ DKK 152.580.0001% mcap0.2% of flowShareOutside a trading venueDK:1362382
12,543 shares@ DKK 108.710.0013% mcap1.6% of flowShareOutside a trading venueDK:1347025
54,669 shares0ShareOutside a trading venueDK:1333439
2,596 shares@ DKK 146.600.0004% mcap0.4% of flowShareNasdaq Copenhagen A/S, XCSEDK:1330866
98,855 shares@ DKK 243.80270.022% mcap27.4% of flowShareNasdaq Copenhagen A/S, XCSEDK:1315150
98,855 shares@ DKK 146.600.013% mcap16.5% of flowShareNasdaq Copenhagen A/S, XCSEDK:1314963
200 shares@ DKK 275.970.0001% mcap0.1% of flowShareNasdaq Copenhagen A/S, XCSEDK:1312612
2,966 shares0ShareOutside a trading venueDK:1294225
823 shares@ DKK 273.250.0002% mcap0.3% of flowShareOutside a trading venueDK:1289504
8,258 shares@ DKK 148.170.0011% mcap1.4% of flowShareOutside a trading venueDK:1280657
26,736 shares@ DKK 108.880.0027% mcap3.3% of flowShareOutside a trading venueDK:1279419
57,836 shares0ShareOutside a trading venueDK:1264735
67,788 shares@ DKK 142.000.0090% mcap11.0% of flowShareNasdaq Copenhagen A/S, XCSEDK:1262459
4,800 shares@ DKK 154.690.0007% mcap0.8% of flowShareNasdaq Copenhagen A/S, XCSEDK:1246283
Ideal exit: 31 May 2024 (T+270)
3,375 shares@ DKK 149.560.0005% mcap0.6% of flowShareNasdaq Copenhagen A/S, XCSEDK:1246015
Ideal exit: 28 May 2024 (T+270)
1,185 shares@ DKK 189.740.0002% mcap0.3% of flowShareOutside a trading venueDK:1233231
9,000 shares@ DKK 155.800.0013% mcap1.6% of flowShareNasdaq Copenhagen A/S, XCSEDK:1229638
12,976 shares@ DKK 99.530.0012% mcap1.5% of flowShareOutside a trading venueDK:1224301
2,313 shares0ShareOutside a trading venueDK:1222422
14,000 shares@ DKK 155.800.0020% mcap2.5% of flowShareNasdaq Copenhagen A/S, XCSEDK:1213965
10,642 shares@ DKK 151.550.0015% mcap1.8% of flowShareOutside a trading venueDK:1210681
5,845 shares@ DKK 126.550.0007% mcap0.8% of flowShareOutside a trading venueDK:1207954
88,325 shares0ShareOutside a trading venueDK:1196330
25 of 81 declarations
About Bavarian Nordic A/S
Bavarian Nordic A/S is a Danish biopharmaceutical company focused on the development of vaccines and treatments for infectious diseases and cancer. It emphasizes innovation in therapeutic and preventive vaccines.
